Integrin α1 subunit is up-regulated in colorectal cancer

被引：27
作者：
Boudjadi S. [1 ,2 ]
Carrier J.C. [1 ,2 ]
Beaulieu J.-F. [1 ]
机构：
[1] Laboratory of Intestinal Physiopathology, Department of Anatomy and Cell Biology, Faculty of Medicine and Heath Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4
[2] Department of Medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4
来源：
Biomarker Research | / 1卷 / 1期
基金：
加拿大健康研究院;
关键词：
Colorectal cancer; Immunohistochemistry staining; Integrin; QPCR; Tissue microarrays;
D O I：
10.1186/2050-7771-1-16
中图分类号：
学科分类号：
摘要：
Background: Colorectal cancer remains one of the leading causes of death from cancer in industrialized countries. Integrins are a family of heterodimeric glycoproteins involved in bidirectional cell signaling and participate in the regulation of cell shape, adhesion, migration, differentiation, gene transcription, survival and proliferation. The α1 subunit is known to be involved in RAS/ERK proliferative pathway activation and plays an important role in mammary carcinoma cell proliferation and migration. In the small intestine, α1 is present in the crypt proliferative compartment and absent in the villus, but nothing is known about its expression in the colon mucosa, or in colorectal cancer. Results: In the present study, we demonstrated that in the colon mucosa, α1 is present in the basolateral domain of the proliferative cells of the crypt, and in the surrounding myofibroblasts. We found higher levels of α1 mRNA in 86% of tumours compared to their corresponding matched margin tissues. Immunohistochemical analysis showed that α1 staining was moderate to high in 65% of tumour cells and 97% of the reactive cells surrounding the tumour cells vs 23% of normal epithelial cells. Conclusion: Our findings suggest an active role for the α1β1 integrin in colorectal cancer progression. © 2013 Boudjadi et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 30 条
[1]  
Aplin A.E., Juliano R.L., Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway, J Cell Sci, 112, PART 5, pp. 695-706, (1999)
[2]  
Giancotti F.G., Integrin signaling: specificity and control of cell survival and cell cycle progression, Curr Opin Cell Biol, 9, pp. 691-700, (1997)
[3]  
Lock R., Debnath J., Extracellular matrix regulation of autophagy, Curr Opin Cell Biol, 20, pp. 583-588, (2008)
[4]  
Desgrosellier J.S., Cheresh D.A., Integrins in cancer: biological implications and therapeutic opportunities, Nat Rev Cancer, 10, pp. 9-22, (2010)
[5]  
Beaulieu J.F., Integrin alpha6beta4 in colorectal cancer, World J Gastrointest Pathophysiol, 1, pp. 3-11, (2010)
[6]  
Teller I.C., Beaulieu J.F., Interactions between laminin and epithelial cells in intestinal health and disease, Expert Rev Mol Med, 3, pp. 1-18, (2001)
[7]  
Basora N., Desloges N., Chang Q., Bouatrouss Y., Gosselin J., Poisson J., Sheppard D., Beaulieu J.F., Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines, Int J Cancer, 75, pp. 738-743, (1998)
[8]  
Dydensborg A.B., Teller I.C., Groulx J.F., Basora N., Pare F., Herring E., Gauthier R., Jean D., Beaulieu J.F., Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity, BMC Cancer, 9, (2009)
[9]  
Ni H., Dydensborg A.B., Herring F.E., Basora N., Gagne D., Vachon P.H., Beaulieu J.F., Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression, Oncogene, 24, pp. 6820-6829, (2005)
[10]  
Barczyk M., Carracedo S., Gullberg D., Integrins, Cell Tissue Res, 339, pp. 269-280, (2010)
123